发明名称 MULTICOMPONENT CRYSTALS COMPRISING DASATINIB AND SELECTED CO-CRYSTAL FORMERS
摘要 Provided are a multicomponent crystalline system (co-crystal), use thereof, as well as a process for obtaining the same. The said multicomponent crystalline system (co-crystal) comprises Dasatinib and a second compound selected from methyM-hydrobenzoate, nicotinamide, ethyl gallate, methyl gallate, propyl gallate, ethyl maltol, vanillin, menthol, or (1R,2S,5R)-(−)-menthol.;
申请公布号 US2015133463(A1) 申请公布日期 2015.05.14
申请号 US201314406339 申请日期 2013.06.13
申请人 BASF SE 发明人 Chiodo Tiziana;Hafner Andreas;Hintermann Tobias;Salvador Beate;Szelagiewicz Martin;Blatter Fritz;Siebenhaar Bernd;Vossen Marcus
分类号 C07D417/12;C07D213/82;A61K31/506;C07C47/58;C07C35/12;C07C65/03;C07D309/40 主分类号 C07D417/12
代理机构 代理人
主权项 1. A multicomponent crystalline system comprising: a compound of formula 1and a second compound selected from the group consisting of methyl-4-hydroxybenzoate, nicotinamide, ethyl gallate, methyl gallate, propyl gallate, ethyl maltol, vanillin, menthol, and (1R,2S,5R)-(−)-menthol.
地址 Ludwigshafen DE